Affiliation: University of Oxford
- Can neuroimaging help us to understand and classify somatoform disorders? A systematic and critical reviewMichael Browning
Department of Psychiatry, University of Oxford, Warneford Hospital, Warneford Lane, Oxford OX3 7JX, UK
Psychosom Med 73:173-84. 2011..two specific questions: Is there evidence of altered neural function or structure that is specifically associated with somatoform disorders? What conclusions can we draw from these findings about the etiology of somatoform disorders?..
- Using attentional bias modification as a cognitive vaccine against depressionMichael Browning
Department of Psychiatry, University of Oxford, Oxford, United Kingdom
Biol Psychiatry 72:572-9. 2012....
- Using an experimental medicine model to explore combination effects of pharmacological and cognitive interventions for depression and anxietyMichael Browning
Department of Psychiatry, University of Oxford, Oxford, UK
Neuropsychopharmacology 36:2689-97. 2011..More generally, the findings suggest that pinpointing the cognitive actions of treatments may inform future development of combination strategies in mental health...
- Lateral prefrontal cortex mediates the cognitive modification of attentional biasMichael Browning
Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, United Kingdom
Biol Psychiatry 67:919-25. 2010..It has been hypothesized, but not proved, that psychological interventions may alter the function of prefrontal regions supervising the allocation of attentional resources...
- The modification of attentional bias to emotional information: A review of the techniques, mechanisms, and relevance to emotional disordersMichael Browning
Department of Psychiatry, University of Oxford, Oxford, England
Cogn Affect Behav Neurosci 10:8-20. 2010..Finally, we suggest a conceptual framework that embraces both pharmacological and psychological approaches and consider the possible implications of this work for future research and treatment development...
- Expectancy and surprise predict neural and behavioral measures of attention to threatening stimuliMichael Browning
Department of Psychiatry, Oxford University, Oxford, UK
Neuroimage 59:1942-8. 2012..These results suggest that continuously calculated estimates of the probability of threat may plausibly be used to influence the deployment of visual attention and that use of this information is perturbed in anxious individuals...
- Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processingJamie Horder
University Department of Psychiatry, Neurosciences Building, Warneford Hospital, Oxford, UK
J Psychopharmacol 26:125-32. 2012..Investigating such effects could be useful in detecting adverse psychiatric effects of novel treatments...
- The use of cognitive bias modification and imagery in the understanding and treatment of depressionMichael Browning
Department of Psychiatry, University of Oxford, UK
Curr Top Behav Neurosci 14:243-60. 2013..In summary, by providing a method for altering habitual cognitive function in experimental and clinical settings CBM techniques have begun to further the understanding of and the treatment for depression...
- Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteersJamie Horder
University Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK
Psychopharmacology (Berl) 205:85-91. 2009..The anti-obesity drug and cannabinoid type 1 receptor antagonist, rimonabant, is associated with significant rates of depression and anxiety in clinical use...
- Early markers of cognitive enhancement: developing an implicit measure of cognitive performanceAbbie Pringle
Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK
Psychopharmacology (Berl) 230:631-8. 2013..These results suggest that the novel learning task should be explored as a biomarker of early cognitive improvement which could be more sensitive than conventional measures. ..